ESTIMATING HIV INCIDENCE AND NUMBER OF UNDIAGNOSED INDIVIDUALS LIVING WITH HIV IN THE EUROPEAN UNION/EUROPEAN ECONOMIC AREA, 2015
Since 2011, human immunodeficiency virus (HIV) incidence appears unchanged in the European Union/European Economic Area with between 29,000 and 33,000 new cases reported annually up to 2015.
European Virus Archive goes global
EVAg is a network of laboratories including 16 EU member state institutions and 9 non-EU institutions, that represent an extensive range of virological disciplines. EVAg establishes close relationships and collaborations with international organizations involved in public health (WHO, OIE and FAO).
EUROPEAN INJURY DATABASE
REQUEST FOR RESEARCH ACCESS
The European Injury Database IDB)contains anonymous data on accidents and injuries from different EU Member States. As injuries are an important and largely preventable health problem, the IDB provides users with relevant information for public health and consumer safety policies and actions within the EU.
Establishing a Global Vaccine-Development Fund
As the Ebola epidemic in West Africa continues, albeit at a much lower level than it reached in the spring, we still lack a vaccine that has been shown to be safe and effective.
Much attention has appropriately been directed at major disease targets such as human immunodeficiency virus (HIV), tuberculosis, and malaria, for which organizations such as the National Institutes of Health, the Bill and Melinda Gates Foundation, and the Wellcome Trust are providing considerable financial support. Similar attention has been devoted to the provision of currently licensed pediatric vaccines, which is supported by GAVI (formerly the Global Alliance for Vaccines and Immunization).